Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Rd.
P.O. Box 368
Ridgefield, CT 06877
Value through InnovationJune 19 2013
U.S. Journalist and Media Contact Information
The contacts listed below are for use by representatives of the news media. If you are not a member of the media and need assistance, we ask that you please contact the company at 1-800-243-0127, Monday through Friday from 8:30 a.m. to 5:00 p.m., excluding holidays.
This contact information is not intended for reporting unexpected drug effects or adverse events for any Boehringer Ingelheim product. Please report any unexpected effects or product problems to the Drug Information Unit by calling 1-800-542-6257 (option 4).
US Headquarters Contact Information
U.S. Corporate Media Inquiries
-
Media Contact - Public Affairs & Communications
U.S. Products and Pipeline Media Inquiries - General
-
Media Contact - U.S. Prescription Medicines, Therapeutic Areas & Pipeline
U.S. Products by Therapeutic Area
-
Media Contact - Cardiovascular & Diabetes
-
Media Contact - Cardiovascular
-
Media Contact - Cardiovascular
-
Media Contact - Diabetes
-
Media Contact - Central Nervous System
-
Media Contact - HIV and Hepatitis C Virus
-
Media Contact - Oncology
-
Media Contact - Respiratory
Jennifer Forsyth
Atrovent® HFA (ipratropium bromide HFA) Inhalation Aerosol
Combivent® (ipratropium bromide and albuterol sulfate)
Spiriva® HandiHaler® (tiotropium bromide inhalation powder)
Chronic Obstructive Pulmonary Disease (COPD)
Idiopathic Pulmonary Fibrosis
Asthma
U.S. Consumer Health Care Inquiries
-
Media Contact - Consumer Health Care
